GWENDOLYN MCDANIEL: Open Payments
NPI 1275548851 · NEWPORT, TN. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,002 in 55 payments from 21 companies in 2025. Trend: 2023 $1,278 · 2024 $990 · 2025 $1,002
Food & beverage: $1,002
| Company | Payments | Amount |
|---|---|---|
| Novo Nordisk Inc | 11 | $153 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 6 | $121 |
| Bayer Healthcare Pharmaceuticals Inc. | 4 | $68 |
| Amgen Inc. | 4 | $63 |
| ABBVIE INC. | 3 | $56 |
| Viatris Specialty LLC | 2 | $54 |
| Lilly USA, LLC | 3 | $53 |
| AstraZeneca Pharmaceuticals LP | 2 | $49 |
| Vanda Pharmaceuticals Inc. | 3 | $49 |
| Mallinckrodt Hospital Products Inc. | 2 | $46 |
Products named: CAPLYTA, Ozempic, Kerendia, UBRELVY, YUPELRI, FARXIGA, ACTHAR, TRELEGY ELLIPTA.
Industry payments across TN — which companies pay providers there.
